Clinical trial
Safety and Efficacy Study in the Treatment of Intestinal Problems Associated…
NCT00110708 · PediaMed Pharmaceuticals, Industry · Unknown status
Key facts
| NCT number | NCT00110708 |
|---|---|
| Title | Safety and Efficacy Study in the Treatment of Intestinal Problems Associated With Autism |
| Official title | A Randomized, Placebo-Controlled Phase II Trial Evaluating Safety and Efficacy of Oral Human Immunoglobulin in the Treatment of Gastrointestinal Dysfunction Associated With Autistic Disorder in Pediatric Patients From 2 to 18 Years of Age |
| Lead sponsor | PediaMed Pharmaceuticals, Industry |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Autism, Autistic Disorder, Child Development Disorders, Pervasive, Gastrointestinal Diseases, Signs and Symptoms, Digestive |
| Intervention type | Drug |
| Interventions | Oralgam (human immunoglobulin) |
| Enrollment | 120 |
| Start date | Apr 1, 2005 |
| Completion | Jun 1, 2006 |
| First posted | May 13, 2005 |
| Last update posted | Feb 22, 2006 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: